These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22991962)

  • 1. Natural carriers for application in tuberculosis treatment.
    Costa H; Grenha A
    J Microencapsul; 2013; 30(3):295-306. PubMed ID: 22991962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis: from molecular pathogenesis to effective drug carrier design.
    Dube D; Agrawal GP; Vyas SP
    Drug Discov Today; 2012 Jul; 17(13-14):760-73. PubMed ID: 22480870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
    Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate and vesicular drug carriers in the management of tuberculosis.
    Rastogi R; Sultana Y; Ali A; Aqil M
    Curr Drug Deliv; 2006 Jan; 3(1):121-8. PubMed ID: 16472101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
    Gelperina S; Kisich K; Iseman MD; Heifets L
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1487-90. PubMed ID: 16151040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal carriers: a rising tool for therapy of tuberculosis.
    Gupta S; Kumar P; Gupta MK; Vyas S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(4):299-53. PubMed ID: 22746187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitubercular inhaled therapy: opportunities, progress and challenges.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic review: tuberculosis.
    Houston S; Pozniak A; Ray CS
    Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
    Pandey R; Sharma S; Khuller GK
    Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of tuberculosis].
    Ramos Espinosa J; Méndez F
    Salud Publica Mex; 1982; 24(3):295-302. PubMed ID: 7147086
    [No Abstract]   [Full Text] [Related]  

  • 15. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate-based sustained release drug delivery systems for tuberculosis.
    Ahmad Z; Khuller GK
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1323-34. PubMed ID: 19040395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growing shadow of tuberculosis.
    Nary G
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):26-7. PubMed ID: 11362486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of the chemotherapy of tuberculosis].
    Brändli O
    Schweiz Rundsch Med Prax; 1986 Nov; 75(47):1405-7. PubMed ID: 3797916
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
    Ullah Z; Athar MT; Samad A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Apr; 53(4):635-40. PubMed ID: 14998985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.